Key terms

About GRTS

Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest GRTS news

Yesterday 7:06am ET Gritstone publishes interim results from Phase 1/2 study of SLATE by TipRanks Apr 08 2:25pm ET Buy Rating Affirmed: Gritstone Oncology’s Promising Growth and Technological Advancements by TipRanks Apr 08 7:16am ET Gritstone presents improvements to EDGE Platform at AACR 2024 by TipRanks Apr 04 11:03am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 03 10:52am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 03 5:32am ET Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Gritstone Oncology (GRTS) by TipRanks Apr 02 7:04am ET Gritstone $32.5M Spot Secondary priced at $1.50 by TipRanks Apr 02 6:16am ET Gritstone price target raised to $5 from $4 at JMP Securities by TipRanks Apr 02 12:25am ET Buy Rating Affirmed for Gritstone Oncology Amid Promising Vaccine Trial Data and Regulatory Potential by TipRanks Apr 01 4:12pm ET Gritstone announces preliminary data from GRANITE study by TipRanks Apr 01 4:12pm ET Gritstone announces offering of common stock and warrants, no amount given by TipRanks Mar 06 7:37am ET Piper Sandler Sticks to Its Buy Rating for Gritstone Oncology (GRTS) by TipRanks Mar 06 6:38am ET Gritstone Oncology’s Strong Financials and Promising Vaccine Trials Fuel Buy Rating by TipRanks Mar 06 6:20am ET Analysts Conflicted on These Healthcare Names: ProKidney (PROK), Gritstone Oncology (GRTS) and MicroPort Scientific (OtherMCRPF) by TipRanks Mar 06 12:30am ET Analysts Offer Insights on Healthcare Companies: Neuronetics (STIM), Marinus (MRNS) and Gritstone Oncology (GRTS) by TipRanks Mar 05 4:27pm ET Gritstone reduced workforce by 40% in February by TipRanks Mar 05 4:26pm ET Gritstone reports FY23 EPS ($1.20) vs ($1.32) last year by TipRanks Mar 01 7:03am ET Buy Rating Affirmed for Gritstone Oncology Amid Strategic Workforce Reduction and Upcoming Trial Catalysts by TipRanks Feb 29 4:19pm ET Gritstone announces 40% reduction in workforce by TipRanks Feb 28 9:57am ET Apollo Global upgraded, Dell initiated: Wall Street’s top analyst calls by TipRanks Feb 28 4:34am ET Gritstone initiated with an Outperform at JMP Securities by TipRanks Feb 28 12:40am ET Analysts Are Bullish on These Healthcare Stocks: Gritstone Oncology (GRTS), Protagonist Therapeutics (PTGX) by TipRanks Feb 13 7:30am ET Analysts Offer Insights on Healthcare Companies: Healthcare Services (HCSG), Gritstone Oncology (GRTS) and Silence Therapeutics (SLN) by TipRanks Feb 13 6:30am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: CymaBay Therapeutics (CBAY), G1 Therapeutics (GTHX) and Gritstone Oncology (GRTS) by TipRanks Feb 13 5:13am ET Buy Rating for Gritstone Oncology: Strategic Progress and Market Potential by TipRanks Feb 12 8:20am ET Gritstone Oncology Postpones Phase 2b COVID-19 Vaccine Trial by TipRanks Feb 12 7:11am ET Gritstone announces update to comparative Phase 2b COVID-19 trial by TipRanks Jan 19 6:28am ET 5 Top Penny Stocks to Buy Now, According to Analysts – January 2024 by TipRanks

No recent news articles are available for GRTS

Apr 14 10:17am ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS by Newsfile Apr 06 10:03am ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS by Newsfile Mar 21 3:24pm ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS by Newsfile Mar 13 12:10pm ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS by Newsfile

GRTS Financials

1-year income & revenue

Key terms

GRTS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

GRTS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel